Difference between revisions of "Xu2017"

(Created page with " <span style="font-size:x-large;"><span style="line-height:normal">'''<span style="font-family:"><span style="color:black">Hyperbaric oxygen therapy improved the proportion go...")
 
Line 95: Line 95:
  
 
<span style="line-height:normal">'''<span style="font-size:10.0pt"><span style="font-family:"><span style="color:black">Appraised by</span></span></span>'''<span style="font-size:10.0pt"><span style="font-family:"><span style="color:black">: Mike Bennett m.bennett@unsw.edu.au; Thursday, 23 January 2020<br/> '''Kill or Update By:''' January 2023</span></span></span></span>
 
<span style="line-height:normal">'''<span style="font-size:10.0pt"><span style="font-family:"><span style="color:black">Appraised by</span></span></span>'''<span style="font-size:10.0pt"><span style="font-family:"><span style="color:black">: Mike Bennett m.bennett@unsw.edu.au; Thursday, 23 January 2020<br/> '''Kill or Update By:''' January 2023</span></span></span></span>
 +
<p style="text-align: center;">&nbsp;</p> <p style="text-align: center;">[[File:Sumhorsa.gif|center|Sumhorsa.gif]]</p>
 +
= [[Stroke|BACK]] =
 +
 +
&nbsp;

Revision as of 03:36, 23 January 2020

Hyperbaric oxygen therapy improved the proportion good outcomes in diabetic patients following haemorrhagic stroke

1. More individuals who had HBOT were deemed to have a good outcome at six months following the haemorrhagic stroke
2. Glycaemic control was improved with HBOT at six months

Citation/s:1. Xu Q, Fan SB, Wan YL, Liu XL, Wang L. The potential long-term neurological improvement of early hyperbaric oxygen therapy on haemorrhagic stroke in the diabetics. Diabetes research and clinical practice. 2018 Apr 1;138:75-80.
Lead author's name and fax: xuqian6521@126.com

Three-part Clinical Question:For patients with diabetes and suffering a haemorrhagic stroke, does the application of hyperbaric oxygen improve outcome?
Search Terms: intracerebral haemorrhage; stroke; diabetes

The Study:Double-blinded concealed randomised controlled trial with intention-to-treat.
The Study Patients: Adult patients with a history of diabetes and presenting to the emergency department within 24 hours of a CT-confirmed haemorrhagic stroke. Excluded if severe (NIHSS >22) or died over the next six months.
Control group (N = 32; 32 analysed): All standard care plus air breathing in a chamber at 1.5 ATA for 60 minutes daily for 30 days.
Experimental group (N = 47; 47 analysed): As above but breathing 100% oxygen at 2.5 ATA.

The Evidence:

Outcome

Time to Outcome

Sham rate

HBO rate

Relative Risk Reduction

Absolute Risk Reduction

NNT

Modified Rankin Score -good outcome (< 2) Range 0 (best) to 5 (worst)

6 months

0.69

0.89

30%

0.21

5

95% CIs:

3% to 57%

0.02 to 0.39

3 to 44

Good Outcome NIHSS (< 3) Range 0 (Best) to 42 (Worst)

6 months

0.56

0.81

44%

0.25

-4

95% Confidence Intervals:

-80% to -7%

0.04 to 0.45

2 to 25

Barthel Index 95 to 100 Range 0 (worst) to 100 (Best)

6 months

0.66

0.85

-30%

-0.195

-5

95% CIs:

0% to 59%

0.001 to 0.39

3 to 682

 

Non-Event Outcomes

Time to outcome/s

Control group

Experimental group

P-value

HbA1c

6 months

9.1 SD 0.82

8.0 SD 0.79

< 0.05

Comments:
1. Intriguing study with interesting outcomes. It should be reproduced elsewhere sooner rather than later as the results seem very important
2. Note planned retrospective exclusion of patients who died within 6 months, but none died.
3. Patients were randomised on a 1 Control :1.5 HBO schedule.
4. Modified Rankin <2 is no symptoms or no significant disability, NIHSS <3 similar and Barthel Index suggests fully independent functioning

Appraised by: Mike Bennett m.bennett@unsw.edu.au; Thursday, 23 January 2020
Kill or Update By: January 2023

 

Sumhorsa.gif

BACK